Neoadjuvant treatment vs no neoadjuvant treatment
Time to recurrence · stage III and IV cutaneous melanoma
It is very uncertain whether neoadjuvant treatment changes time to recurrence (TTR),measured by the number of disease… compared with no neoadjuvant treatment (very low certainty).
1 finding from 1 review
- Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes onlyHR 0.51 [0.22, 1.17]2 studies · 171 participantsVery low